Clinical Trials List
Protocol Number102-5669A
2014-05-21 - 2017-07-31
Others
Terminated1
ICD-10C22.1
Intrahepatic bile duct carcinoma
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9155.1
Malignant neoplasm of intrahepatic bile ducts
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Principal Investigator
Co-Principal Investigator
- Kun-Ju Lin Division of Nuclear Medicine
- Tai-Sen Yeh Division of General Surgery
- Jing-Ren Tseng Division of Nuclear Medicine
- Gigin Lin Division of Radiology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
0 participants
